0.00
Durect Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
See More
Previous Close:
$1.91
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$59.31M
Revenue:
$8.59M
Net Income/Loss:
$-17.07M
P/E Ratio:
0.00
EPS:
-0.61
Net Cash Flow:
$-21.90M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Durect Corp Stock (DRRX) Company Profile
Name
Durect Corp
Sector
Phone
(408) 777-1417
Address
10240 BUBB ROAD, CUPERTINO, CA
Compare DRRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DRRX
Durect Corp
|
0.00 | 59.31M | 8.59M | -17.07M | -21.90M | -0.61 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-30-20 | Initiated | Chardan Capital Markets | Buy |
| Oct-12-20 | Initiated | ROTH Capital | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jan-31-20 | Initiated | B. Riley FBR | Buy |
| Nov-18-19 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-18 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-20-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-20-17 | Reiterated | Laidlaw | Buy |
| Oct-20-17 | Downgrade | Stifel | Buy → Hold |
| Jul-12-17 | Upgrade | Stifel | Hold → Buy |
| Feb-28-17 | Resumed | H.C. Wainwright | Buy |
| Apr-25-16 | Initiated | Rodman & Renshaw | Buy |
| May-01-15 | Reiterated | Cantor Fitzgerald | Buy |
| May-01-15 | Reiterated | Stifel | Buy |
| Mar-25-13 | Initiated | Stifel | Buy |
| Nov-01-12 | Downgrade | C.K. Cooper | Buy → Hold |
| Aug-17-12 | Initiated | C.K. Cooper | Buy |
| Jun-23-09 | Initiated | Caris & Company | Buy |
| Mar-26-09 | Initiated | Wedbush Morgan | Hold |
View All
Durect Corp Stock (DRRX) Latest News
How currency fluctuations impact DURECT Corporation stockTrade Risk Report & Safe Entry Trade Signal Reports - Newser
How strong is DURECT Corporation (DC8A) stock earnings growthWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
How geopolitical tensions affect DURECT Corporation stockSwing Trade & Weekly Watchlist for Hot Stocks - Newser
Can DURECT Corporation (DC8A) stock survive global slowdown2025 Risk Factors & Expert Curated Trade Setups - Newser
Why analysts recommend DURECT Corporation (DC8A) stockBear Alert & Daily Stock Trend Watchlist - Newser
Will DURECT Corporation (DC8) stock beat growth indexes2025 Biggest Moves & AI Driven Stock Reports - Newser
Will DURECT Corporation stock gain from strong economy2025 Retail Activity & Daily Profit Maximizing Trade Tips - BỘ NỘI VỤ
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health (PR Newswire) - Aktiellt
Can DURECT Corporation (DC8) stock surprise markets with earningsWatch List & Stepwise Trade Signal Guides - newser.com
Why DURECT Corporation (DC8) stock could be top winnerJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
How DURECT Corporation (DC8) stock behaves under inflation pressureJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Can DURECT Corporation stock resist market sell offsInflation Watch & Consistent Return Investment Signals - newser.com
Is DURECT Corporation stock recession proofCEO Change & Short-Term High Return Ideas - newser.com
Custom watchlist performance reports with DURECT CorporationBond Market & Long-Term Safe Investment Plans - newser.com
Is DURECT Corporation (DC8A) stock undervalued historically2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
Will DURECT Corporation stock return to pre crisis levelsTrade Risk Summary & Technical Pattern Alert System - newser.com
Will DURECT Corporation stock deliver better than expected guidanceJuly 2025 Chart Watch & Advanced Technical Analysis Signals - newser.com
How DURECT Corporation (DC8) stock benefits from digital adoptionEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com
What catalysts could drive DURECT Corporation stock higher2025 Major Catalysts & Smart Allocation Stock Tips - newser.com
How supply chain issues affect DURECT Corporation stockEarnings Overview Summary & Safe Entry Point Identification - newser.com
How resilient is DURECT Corporation stock in market downturns2025 Technical Overview & Technical Pattern Alert System - newser.com
Why DURECT Corporation (DC8A) stock trades below fair value2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
How DURECT Corporation (DC8A) stock moves on employment dataMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
How reliable is DURECT Corporation (DC8A) stock dividend growthEarnings Miss & High Conviction Buy Zone Alerts - newser.com
Durect Corp Stock (DRRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):